who invented glp-1 drugs Obesity-drug pioneers win prestigious Lasker Award for medical science Richard DiMarchi, pioneering IU peptide
Description
The incretin system has become an important target in the treatment of type 2 diabetes in recent years, and glucagon-like peptide 1 (GLP-1) is of particular interest for its glucose-lowering effects
They're not the same medication
Heres what evidence says about absorption and claims, plus safety checks and questions to ask your clinician.
"Microdosing" GLP-1: case studies and research are showing it helps reduce inflammation, improve cognitive function, and so much more than just weight loss
however, this contradicts established trial data favoring SGLT2 inhibitors for heart failure and should be interpreted cautiously due to possible residual confounding
